Xcout Intel
Magnus Medical, Inc.
Magnus Medical, Inc. is a privately held therapeutic neuromodulation company founded in 2020 to advance precision medicine in brain health. The company protects and develops intellectual property behind therapies such as the SAINT therapy system.
Subscribe to see Magnus Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Magnus Medical, Inc. at a glance
Magnus Medical, Inc. is a neurotech company headquartered in United States. Its most recent funding round raised $49M in May 2025. Xcout tracks 16 named people at Magnus Medical, Inc., including Achal Singh Achrol (Chief Executive Officer).
Magnus Medical, Inc. leadership
- Achal Singh AchrolChief Executive Officer
- Christian GormsenChief Executive Officer
- Brandon BentzleyCo-Founder Chief Medical Officer Board Member
- Romain Moreau-GobardSenior Vice President of Technology
- David DangVP of Finance
- Dee KolanekVice President of Market Access Reimbursement
10 more named people on record for Magnus Medical, Inc., with roles, board committees and tenure — see the full roster →
Magnus Medical, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $49M | — | |
| SEC Form D filing | $40.3M | — | |
| — | $25M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Magnus Medical, Inc. competitors
A few of Magnus Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
BrainEver is a privately held biopharmaceutical company headquartered in Paris, France, focused on developing a pipeline of novel therapies.
AgeneBio, Inc. is a development-stage CNS biopharmaceutical company located in Baltimore, Maryland, focused on discovering and developing innovative therapeutics to preserve and restore brain function.
RAPT Ventures, Inc. develops home-based neuroscience products that utilize structured auditory experiences to enhance and maintain brain performance. The company leverages neuroplasticity to support cognitive functions and brain structure across all life stages, ranging from language processing foundations in infants to neural system maintenance in older adults.
INBRAIN Neuroelectronics develops graphene-based brain-computer interface (BCI) platforms and AI-driven neurotherapeutics designed to decode and modulate neural signals. The company serves patients with brain disorders and neurological conditions, such as Parkinson's disease, by providing real-time, personalized autonomous therapy.
Cognito Therapeutics Ltd. is a clinical-stage company headquartered in Cambridge, Massachusetts, that has conducted multiple clinical studies for its therapeutic products.
Get Magnus Medical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Magnus Medical, Inc. in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access